23andMe customers might just play a role in helping create one of Big Pharma’s next blockbuster drugs. On Wednesday, the genetic testing company announced it was entering a partnership with pharmaceutical giant GlaxoSmithKline (GSK) to develop new drugs and therapies. As part of the collaboration, the company will…
